Laboratorios Farmaceuticos Rovi
ROVI.MC
#3677
Rank
NZ$6.46 B
Marketcap
NZ$126.36
Share price
-4.54%
Change (1 day)
4.71%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2026 (TTM): NZ$0.48 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are NZ$0.89 Billion. In 2025 the company made an earning of NZ$0.39 Billion a decrease over its 2024 earnings that were of NZ$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.48 B22.47%
2025 NZ$0.39 B-25.47%
2024 NZ$0.52 B-8.41%
2023 NZ$0.57 B15.62%
2022 NZ$0.49 B29.09%
2021 NZ$0.38 B149.21%
2020 NZ$0.15 B79.92%
2019 NZ$86.34 M128.6%
2018 NZ$37.77 M0.14%
2017 NZ$37.72 M-35.41%
2016 NZ$58.39 M28.52%
2015 NZ$45.43 M-32.56%
2014 NZ$67.37 M8.45%
2013 NZ$62.12 M-4.24%
2012 NZ$64.87 M2.62%
2011 NZ$63.22 M-3.29%
2010 NZ$65.36 M